Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug2672 | Office FU Wiki | 1.00 |
| drug48 | 2: No instruction regarding positioning Wiki | 1.00 |
| drug38 | 1: Prone positioning Wiki | 1.00 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| D054058 | Acute Coronary Syndrome NIH | 0.41 |
| D013577 | Syndrome NIH | 0.09 |
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
The aim is to compare the safety of using telemedicine and office visit follow-up in post-acute coronary syndrome patients
Description: Major adverse cardiac and cerebrovascular events: cardiac death, myocardial infarction, or stroke
Measure: MACCE Time: 1 yearDescription: High Level of Medical Therapy Optimization is defined as a participant meeting all of the following goals: LDL < 1.4 mmol/L and on any statin, blood pressure < 140/90 mm/Hg (<135/85 mm/Hg for patients with diabetes mellitus), on aspirin or other antiplatelet or anticoagulant, and not smoking. High level of medical therapy optimization is missing if any of the individual goals are missing.
Measure: High level of MT optimization Time: 1 yearDescription: Blood pressure < 140 mm/Hg (<135/85 mm/Hg for for patients with diabetes mellitus)
Measure: PB < 140/90 mm/Hg (<135/85 mm/Hg for Diabetes) Time: 1 yearDescription: Low density lipoprotein< 1.4 mmol/L
Measure: LDL < 1.4 mmol/L Time: 1 yearDescription: Not smoking
Measure: Not smoking Time: 1 yearDescription: Decrease in overweight
Measure: Decrease in overweight Time: 1 yearDescription: Adherence to aspirin or other antiplatelet or anticoagulant
Measure: Aspirin or other antiplatelet or anticoagulant Time: 1 yearDescription: Adherence to prescribed at discharge medication
Measure: Adherence to prescribed medication Time: 1 yearDescription: Hospitalization for cardiac reasons
Measure: Hospitalization Time: 1 yearAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports